HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boots restructuring

This article was originally published in The Rose Sheet

Executive Summary

UK beauty manufacturer and retailer Boots will eliminate 900 positions affecting all support and central functions in its Nottingham headquarters and some regional stores, company announces Jan. 16. Effort is aimed at modernizing the business to develop "simpler and more responsive" business model. Headcount reduction will take place over six months, translating to full year savings of $71 mil. (£1=$1.82), of which $9.1 mil. has been reinvested in new roles. Expected total cost is $85.6 mil., with $54.6 mil. charge to be taken in the current financial year, Boots says. Announcement comes on the heels of "getting in shape" cost savings program announced in 2002 aimed at achieving $182 mil. savings...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011818

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel